The Australian Government’s Medical Research Future Fund (MRFF) has invested $28 million in funding for Monash research projects that incorporate cardiovascular disease, diabetes, traumatic brain injury, COVID-19, stem cell therapies, international clinical trials and the development of Australia’s transfusion data infrastructure.

The projects are part of the Government’s long-term investment into world-leading medical research projects to improve the lives of all Australians.

Monash University President and Vice-Chancellor Professor Margaret Gardner AC said this MRFF funding would support projects making a tangible difference to the lives of patients and their families.

“These MRFF grants acknowledge the outstanding and innovative work of Monash researchers, and the positive contributions they are making to support thriving communities across Australia and the world,” Professor Gardner said. “I warmly congratulate the research teams for this well-deserved recognition.”

Deputy Dean of Research for the Faculty of Medicine, Nursing and Health Sciences, Professor James Whisstock, said this latest round of MRFF funding recognises the significant breadth and diversity of research at Monash and speaks to our focus on healthy, thriving communities.

"This funding will help continue to progress some of our most important research programs to make a positive difference. Many congratulations to all the researchers and their fantastic teams,” Professor Whisstock said.